News

News

TSO3 Sets Third Quarter 2016 Conference Call for Monday, November 7, 2016 at 10:30 a.m. EST

Québec City, October 25, 2016 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Monday, November 7, 2016 at 10:30 a.m. Eastern Standard Time, to discuss its financial results to its fiscal third quarter ended September 30, 2016. Financial results will be issued in a press release prior to the call.

Read more

News

TSO3 to Present at Upcoming Investor Conferences

Québec City, August 4, 2016 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at two financial conferences being held in August 2016.

Read more

News

TSO3 Simplifies Sterilization of Complete Heavy-Duty, Battery-Powered Orthopedic Instrument Sets

Québec City, Québec – July 25, 2016 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, has completed sterile efficacy validation for multiple, heavy-duty battery-powered orthopedic instrument sets in a single sterilization cycle of the Company’s STERIZONE® VP4 Sterilizer.

Read more

News

TSO3 Prepares for European Product Launch

Québec City, Québec – July 18, 2016 – TSO3 Inc. (TSX: TOS) (« TSO3 » or the « Company »), an innovator in sterilization technology for medical devices in healthcare settings, today announced a series of initiatives in support of a planned European launch of the Company’s STERIZONE® VP4 Sterilizer this year.

Read more